ENETS guidelines for the management of gastroduodenal and colorectal neuroendocrine neoplasms

Medical advisors

This course has been developed in close cooperation with:
Prof. Martyn Caplin, Prof. Gianfranco Delle Fave, and Prof. Andreas Pascher
ENETS CME course editor: Dr. Christos Toumpanakis

Target audience

The target audience for this course comprises clinicians in the field of oncology, radiology, surgery, endocrinology, gastroenterology, and pathology. The target audience is expected to have a background knowledge of NEN biology, epidemiology, WHO classification and survival, and prognostic factors.

Length of webinar

60 minutes

Date of webinar

Begin: 28 January 2019
End: 27 January 2021

Accreditation

1 European CME credit (ECMEC)

Disclosure

Prof. Martyn Caplin, Prof. Gianfranco Delle Fave, and Prof. Andreas Pascher, who are responsible for the medical content, received editorial and writing support in the preparation of this course. The medical advisors are fully responsible for the content and editoral decisions for this course.

Agnieszka Rarok, PhD and Francisco Hernandez, PhD provided scientific advisory support for this course.

Jenny Lloyd, BSc, PhD, provided writing and editorial support for this course.

Acknowledgement

An independent review of this course was conducted by Dr Erika Kovačič Palli, Gastroenterološka interna klinika, Japljeva ulica 2, 1000 Ljubljana, Slovenia.

Technical information

This webinar was previously provided in flash file format. Due to security reasons it has been remastered and converted into HTML5 standard.

Whenever you're prompted to click on something during the webinar, please just stop the video. (In the previous version of the webinar, clicking would lead to a freeze frame picture). You may also go back and repeat sequences whenever you like if you need additional time for listening or reading.

Upon completion of this course and its accompanying self-assessment questions, learners should know the guidelines for the management of gastroduodenal and coloroectal Neuroendocrine neoplasms, including:

  • Clinical diagnosis
  • Diagnostic procedures
  • Treatment
  • Management of advanced/metastatic disease
  • Follow-up.